(1E)-1-methyl-5-methylidene-8-propan-2-ylcyclodeca-1,6-diene

Details

Top
Internal ID d8496f25-f848-4ace-af57-b3e3be8a4128
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Germacrane sesquiterpenoids
IUPAC Name (1E)-1-methyl-5-methylidene-8-propan-2-ylcyclodeca-1,6-diene
SMILES (Canonical) CC1=CCCC(=C)C=CC(CC1)C(C)C
SMILES (Isomeric) C/C/1=C\CCC(=C)C=CC(CC1)C(C)C
InChI InChI=1S/C15H24/c1-12(2)15-10-8-13(3)6-5-7-14(4)9-11-15/h7-8,10,12,15H,3,5-6,9,11H2,1-2,4H3/b10-8?,14-7+
InChI Key GAIBLDCXCZKKJE-NWYXHMAXSA-N
Popularity 136 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24
Molecular Weight 204.35 g/mol
Exact Mass 204.187800766 g/mol
Topological Polar Surface Area (TPSA) 0.00 Ų
XlogP 4.70
Atomic LogP (AlogP) 4.89
H-Bond Acceptor 0
H-Bond Donor 0
Rotatable Bonds 1

Synonyms

Top
(1E,6E)-1-methyl-5-methylidene-8-(propan-2-yl)cyclodeca-1,6-diene
37839-63-7
F82396

2D Structure

Top
2D Structure of (1E)-1-methyl-5-methylidene-8-propan-2-ylcyclodeca-1,6-diene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9917 99.17%
Caco-2 + 0.8959 89.59%
Blood Brain Barrier + 0.9500 95.00%
Human oral bioavailability + 0.7571 75.71%
Subcellular localzation Lysosomes 0.4651 46.51%
OATP2B1 inhibitior - 0.8593 85.93%
OATP1B1 inhibitior + 0.9618 96.18%
OATP1B3 inhibitior + 0.9412 94.12%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior - 0.7425 74.25%
P-glycoprotein inhibitior - 0.9497 94.97%
P-glycoprotein substrate - 0.8867 88.67%
CYP3A4 substrate - 0.5573 55.73%
CYP2C9 substrate - 0.8164 81.64%
CYP2D6 substrate - 0.7751 77.51%
CYP3A4 inhibition - 0.9422 94.22%
CYP2C9 inhibition - 0.8228 82.28%
CYP2C19 inhibition - 0.7961 79.61%
CYP2D6 inhibition - 0.9409 94.09%
CYP1A2 inhibition - 0.6853 68.53%
CYP2C8 inhibition - 0.8543 85.43%
CYP inhibitory promiscuity - 0.7758 77.58%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.6700 67.00%
Carcinogenicity (trinary) Warning 0.5024 50.24%
Eye corrosion + 0.5274 52.74%
Eye irritation + 0.5672 56.72%
Skin irritation + 0.7425 74.25%
Skin corrosion - 0.9779 97.79%
Ames mutagenesis - 0.8000 80.00%
Human Ether-a-go-go-Related Gene inhibition - 0.3620 36.20%
Micronuclear - 0.9900 99.00%
Hepatotoxicity - 0.5300 53.00%
skin sensitisation + 0.8987 89.87%
Respiratory toxicity - 0.6778 67.78%
Reproductive toxicity - 0.7889 78.89%
Mitochondrial toxicity - 0.7000 70.00%
Nephrotoxicity - 0.6717 67.17%
Acute Oral Toxicity (c) III 0.8141 81.41%
Estrogen receptor binding - 0.9607 96.07%
Androgen receptor binding - 0.8279 82.79%
Thyroid receptor binding - 0.6842 68.42%
Glucocorticoid receptor binding - 0.7441 74.41%
Aromatase binding - 0.9074 90.74%
PPAR gamma - 0.8182 81.82%
Honey bee toxicity - 0.8608 86.08%
Biodegradation + 0.5500 55.00%
Crustacea aquatic toxicity + 0.5500 55.00%
Fish aquatic toxicity + 0.9974 99.74%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 92.74% 97.25%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.64% 95.56%
CHEMBL3359 P21462 Formyl peptide receptor 1 84.30% 93.56%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 83.74% 96.47%
CHEMBL1907594 P30926 Neuronal acetylcholine receptor; alpha3/beta4 82.76% 97.23%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 82.73% 91.11%
CHEMBL1994 P08235 Mineralocorticoid receptor 82.14% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 82.13% 95.89%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.45% 97.09%
CHEMBL1871 P10275 Androgen Receptor 81.33% 96.43%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 80.89% 95.89%

Cross-Links

Top
PubChem 74764030
NPASS NPC300649